Picture of Takeda Pharmaceutical Co logo

TAK Takeda Pharmaceutical Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - Wellington Mngmnt Gp Shire plc Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Limited

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181205:nRSE5410Ja

RNS Number : 5410J
Wellington Management Group LLP
05 December 2018
 
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 1.                        KEY INFORMATION
 (a)         Full name of discloser:                                                                                                                                                                         Wellington Management Group LLP
 (b)         Owner or controller of interests and short positions disclosed, if different
             from 1(a):
             The naming of nominee or vehicle companies is insufficient. For a trust, the
             trustee(s), settlor and beneficiaries must be named.
 (c)         Name of offeror/offeree in relation to whose relevant securities this form                                                                                                                      Takeda Pharmaceutical Company Limited
             relates:
             Use a separate form for each offeror/offeree
 (d)         If an exempt fund manager connected with an offeror/offeree, state this and
             specify identity of offeror/offeree:
 (e)         Date position held/dealing undertaken:                                                                                                                                                          04 December 2018
             For an opening position disclosure, state the latest practicable date prior to
             the disclosure
 (f)         In addition to the company in 1(c) above, is the discloser making disclosures                                                                                                                   YES
             in respect of any other party to the offer?
                                                                                                                                                                                               Shire PLC
             If it is a cash offer or possible cash offer, state "N/A"
 2.                        POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 If there are positions or rights to subscribe to disclose in more than one
 class of relevant securities of the offeror or offeree named in 1(c), copy
 table 2(a) or (b) (as appropriate) for each additional class of relevant
 security.
 (a)                       Interests and short positions in the relevant securities of the offeror or
                           offeree to which the disclosure relates following the dealing (if any)
 Class of relevant security:                                                                                                          Common Stock (JP3463000004)
                                                                                                                                      Interests                                                                                                                        Short Positions
                                                                                                                                      Number                                                                           %                                               Number                                                    %
 (1)         Relevant securities owned and/or controlled:                                                                             16,614,797                                                                       2.09 %                                          63,184                                                    0.01 %
 (2)         Cash-settled derivatives:
 (3)         Stock-settled derivatives (including options) and agreements to purchase/sell:
             Total                                                                                                                    16,614,797 *                                                                     2.09 %                                          63,184                                                    0.01 %
 *Wellington Management Group LLP does not have discretion regarding voting
 decisions in respect of 12,590,383 shares that are included in the total
 above.
 All interests and all short positions should be disclosed.
 Details of any open stock-settled derivative positions (including traded
 options), or agreements to purchase or sell relevant securities, should be
 given on a Supplemental Form 8 (Open Positions).
 (b)                       Rights to subscribe for new securities (including directors' and other
                           employee options)
 Class of relevant security in relation to which subscription right exists:
 Details, including nature of the rights concerned and relevant percentages:
 3.                        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 Where there have been dealings in more than one class of relevant securities
 of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
 appropriate) for each additional class of relevant security dealt in.
 The currency of all prices and other monetary amounts should be stated.
 (a)                       Purchases and sales
 Class of relevant security                                                                                   Purchase/sale                                                              Number of securities                                                                        Price per unit
 Common Stock (JP3463000004)                                                                                  Purchase                                                                   162,418                                                                                     4,193.1748 JPY
 Common Stock (JP3463000004)                                                                                  Purchase                                                                   130,400                                                                                     4,195.7270 JPY
 (b)                       Cash-settled derivative transactions
 Class of relevant security                             Product description e.g. CFD                                                                   Nature of dealing e.g. opening/closing a long/short position,                                     Number of reference securities                  Price per unit
                                                                                                                                                       increasing/reducing a long/short position
 (c)                       Stock-settled derivative transactions (including options)
 (i)                       Writing, selling, purchasing or varying
 Class of relevant security              Product description e.g. call option         Writing, purchasing, selling, varying etc.      Number of securities to which option relates       Exercise price per unit                           Type e.g. American, European etc.         Expiry date                  Option money paid/ received per unit
 (ii)                      Exercise
 Class of relevant security                                            Product description e.g. call option                                                             Exercising/ exercised against                            Number of securities                                          Exercise price per unit
 (d)                       Other dealings (including subscribing for new securities)
 Class of relevant security                                                                                   Nature of dealing e.g. subscription, conversion                            Details                                                                                     Price per unit (if applicable)
 4.                        OTHER INFORMATION
 (a)                       Indemnity and other dealing arrangements
 Details of any indemnity or option arrangement, or any agreement or
 understanding, formal or informal, relating to relevant securities which may
 be an inducement to deal or refrain from dealing entered into by the person
 making the disclosure and any party to the offer or any person acting in
 concert with a party to the offer:
 Irrevocable commitments and letters of intent should not be included. If there
 are no such agreements, arrangements or understandings, state "none"
 None
 (b)                       Agreements, arrangements or understandings relating to options or derivatives
 Details of any agreement, arrangement or understanding, formal or informal,
 between the person making the disclosure and any other person relating to:
 (i) the voting rights of any relevant securities under any option; or
 (ii) the voting rights or future acquisition or disposal of any relevant
 securities to which any derivative is referenced:
 If there are no such agreements, arrangements or understandings, state "none"
 None
 (c)                       Attachments
 Is a Supplemental Form 8 (Open Positions) attached?                                                                                                                                               NO
 Date of disclosure                                                                                                                                                                                05 December 2018
 Contact name                                                                                                                                                                                      Meredith Smart
 Telephone number                                                                                                                                                                                  44-20-7126-6311
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.
 

Recent news on Takeda Pharmaceutical Co

See all news